Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.56
+0.78 (16.32%)
At close: Jun 6, 2025, 4:00 PM
5.49
-0.07 (-1.26%)
After-hours: Jun 6, 2025, 5:45 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $179.01 million as of June 6, 2025. Its market cap has increased by 18.33% in one year.
Market Cap
179.01M
Enterprise Value
30.61M
1-Year Change
18.33%
Ranking
Category
Stock Price
$5.56
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $179.01M, a decrease of -49.55%. That is a compound annual growth rate of -30.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 153.89M | 6.22% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 689.91B |
| Johnson & Johnson | 372.24B |
| AbbVie | 335.30B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 274.09B |
| Abbott Laboratories | 232.36B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |